ArticleBlood advances2023
Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis.
Parth Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it